LYRM03 is a ubenimex-derived aminopeptidase inhibitor that attenuates LPS-induced acute lung injury in mice. It functions by suppressing pro-inflammatory mediator expression and inhibiting MyD88-dependent TLR4 signaling in alveolar macrophages, highlighting its potential for sepsis-related lung injury research.
Molecular Weight:
407.5
CAS Number:
[1820750-36-4]
Formula:
C21H33N3O5
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted